About VanEck Global Healthcare Leaders ETF

HLTH invests in stocks. The fund's major sectors are Health Technology, with 89.71% stocks, and Health Services, with 10.26% of the basket. The assets are mostly located in the North America region.

HLTH top holdings are Corcept Therapeutics Incorporated. and United Therapeutics Corporation, occupying 2.32% and 2.18% of the portfolio correspondingly.

HLTH last dividends amounted to 0.02 AUD. The year before, the issuer paid 0.09 AUD in dividends, which shows a 350.00% decrease.

HLTH assets under management is ‪48.18 M‬ AUD. It's risen 0.83% over the last month.

HLTH fund flows account for ‪−4.44 M‬ AUD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

HLTH shares are issued by Van Eck Associates Corp. under the brand VanEck. The ETF was launched on Sep 8, 2020, and its management style is Passive.

HLTH expense ratio is 0.45% meaning you'd have to pay 0.45% of your investment to help manage the fund.

HLTH follows the MarketGrader Developed Markets ex-Australia Health Care Index - AUD. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

HLTH invests in stocks.

HLTH price has fallen by −0.35% over the last month, and its yearly performance shows a 0.62% increase. See more dynamics on HLTH price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −0.91% over the last month, have fallen by −0.91% over the last month, showed a 2.00% increase in three-month performance and has increased by 0.41% in a year.